Compare QUALCOMM, Inc. (QCOM) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
QUALCOMM, Inc. vs Smith & Nephew plc — how do they compare? QUALCOMM, Inc. trades at $175.5 (market cap $187.95B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: QUALCOMM, Inc. is far larger — about 16.9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold QUALCOMM, Inc. for 87 Days and Smith & Nephew plc for 121 Days on average.
| QCOM | SNN | |
|---|---|---|
Market Cap | $187.95B | $11.10B |
Volume | 9,535,042 | 1,051,703 |
Sector | Technology | Health |
52-Week High | $251.10 | $37.17 |
52-Week Low | $124.07 | $26.42 |
Typical Hold Time | 87 Days | 121 Days |
Enterprise Value | $194.92B | $14.13B |
Dividend Yield | 2.09% | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Qualcomm (QCOM) trades at $176.01, down 0.59% on the day, with a bearish technical signal and key support at $173. The company reported mixed Q2 2026 earnings, missing EPS estimates, but maintains strong profitability with a 21.01% net margin and 33.75% ROE. Recent news highlights a transformative $60 billion AI partnership with Amazon, boosting sentiment despite near-term volatility.
QCOM presents a compelling risk-reward profile with a consensus price target of $204.48, implying 16% upside. Strengths include robust cash flow and diversification into AI/data centers, but risks involve execution on new initiatives and dependence on smartphone markets. Analyst consensus leans Hold, reflecting cautious optimism amid competitive pressures.
SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.
The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
